SCHEMBL29588239

SCHEMBL29588239

CC(C)c1ccc(OCc2ccccc2)c(S(N)(=O)=O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1D P25100 1/20 0.52
▸ ADRA1A P35348 1/20 0.52
▸ ADRA1B P35368 1/20 0.52
▸ P2RX4 Q99571 1/20 0.48
▸ CA1 P00915 2/20 0.44
▸ CA2 P00918 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ CA12 O43570 1/20 0.44
▸ CA4 P22748 1/20 0.44
▸ CA5A P35218 1/20 0.44
▸ CA7 P43166 1/20 0.44
▸ CA5B Q9Y2D0 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CYP19A1 P11511 1/20 0.41
▸ ALPL P05186 1/20 0.41
▸ STAT3 P40763 1/20 0.41
▸ GLRA1 P23415 1/20 0.41
▸ KMT2A Q03164 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22588505 1.00 ADRA1D (0.52) ADRA1DADRA1AADRA1BP2RX4CA1
SCHEMBL24313621 0.86 GLRA1 (0.44) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2
SCHEMBL29469893 0.81 ALDH1A1 (0.59) ADRA1DADRA1AADRA1BCA1CA2
SCHEMBL29588816 0.80 MRGPRX4 (0.50) ADRA1DADRA1AADRA1BP2RX4CA1
SCHEMBL22587775 0.80 MRGPRX4 (0.50) ADRA1DADRA1AADRA1BP2RX4CA1
SCHEMBL682767 0.79 MAPT (0.49) ALDH1A1SMN1; SMN2HPGDGLRA1KMT2A
SCHEMBL14200026 0.79 MAPT (0.45) ALDH1A1SMN1; SMN2GLRA1GAA
SCHEMBL1013565 0.78 CA1 (0.56) ADRA1DADRA1AADRA1BP2RX4CA1
SCHEMBL11879060 0.77 P2RX4 (0.55) ADRA1DADRA1AADRA1BP2RX4ALDH1A1
SCHEMBL12889910 0.77 GLRA1 (0.50) ADRA1DADRA1AADRA1BALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229045-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute Inc. (US) 2023-08-23 — — EP disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 — — WO disclosed
Send feedback